Lionsgate Studios awarded Susan McCaw 13,405 shares at $0 per share, leaving her with 114,431 shares after the transaction. For investors tracking LION ownership, the award represents about 11.7% of McCaw’s resulting holding, giving a precise measure of the director’s post-transaction position.
Key Highlights
- Susan McCaw received 13,405 Lionsgate Studios shares with no per-share consideration.
- Her reported position after the award was 114,431 shares.
- The transaction represented about 11.7% of her resulting shareholding.
Lionsgate Studios Corp. (NYSE: LION) is a Movies/Entertainment company. Susan McCaw received an award of 13,405 shares, while her position after the transaction stood at 114,431 shares.
Award Recorded at $0 Per Share
The transaction took place on 15 September 2026. McCaw is identified as a Director of Lionsgate Studios Corp. The transaction relates to Lionsgate Studios shares.
Resulting Position Represents 11.7%
McCaw’s post-transaction holding was reported at 114,431 shares. The award represented about 11.7% of that resulting position.
FAQs
Q: How many Lionsgate Studios shares did Susan McCaw receive?
A: Susan McCaw received 13,405 Lionsgate Studios shares. The award was recorded at $0 per share on 15 September 2026.
Q: What was Susan McCaw’s LION shareholding after the award?
A: McCaw’s resulting Lionsgate Studios holding was 114,431 shares. The reported total reflects her position after the share award.
Q: What percentage of Susan McCaw’s holding did the award represent?
A: The Lionsgate Studios share award represented about 11.7% of McCaw’s resulting holding. That percentage is tied to the 114,431 shares reported after the transaction.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.